8 0 1 0 1 B-lower_bound
years 2 7 2 7 I-lower_bound
of 8 10 8 10 O
age 11 14 11 14 B-age
or 15 17 15 17 O
older 18 23 18 23 O

Allergies 0 9 24 33 O
to 10 12 34 36 O
Lidocaine 13 22 37 46 B-allergy_name
or 23 25 47 49 O
Novocain 26 34 50 58 B-allergy_name

Allergies 0 9 59 68 O
to 10 12 69 71 O
imaging 13 20 72 79 B-allergy_name
dyes 21 25 80 84 I-allergy_name

Bilirubin 0 9 85 94 B-clinical_variable
≤ 10 11 95 96 O
2 12 13 97 98 B-upper_bound
times 14 19 99 104 I-upper_bound
upper 20 25 105 110 I-upper_bound
limit 26 31 111 116 I-upper_bound
of 32 34 117 119 I-upper_bound
normal 35 41 120 126 I-upper_bound

Concurrent 0 10 127 137 B-treatment
treatment 11 20 138 147 I-treatment
with 21 25 148 152 I-treatment
another 26 33 153 160 I-treatment
anti 34 38 161 165 I-treatment
- 38 39 165 166 I-treatment
estrogen 39 47 166 174 I-treatment

Creatinine 0 10 175 185 B-clinical_variable
≤ 11 12 186 187 O
2 13 14 188 189 B-upper_bound
times 15 20 190 195 I-upper_bound
upper 21 26 196 201 I-upper_bound
limit 27 32 202 207 I-upper_bound
of 33 35 208 210 I-upper_bound
normal 36 42 211 217 I-upper_bound

Depressed 0 9 218 227 B-chronic_disease
bone 10 14 228 232 I-chronic_disease
marrow 15 21 233 239 I-chronic_disease

Diagnosis 0 9 240 249 O
of 10 12 250 252 O
inflammatory 13 25 253 265 B-cancer
breast 26 32 266 272 I-cancer
carcinoma 33 42 273 282 I-cancer

Diagnosis 0 9 283 292 O
of 10 12 293 295 O
triple 13 19 296 302 B-cancer
- 19 20 302 303 I-cancer
negative 20 28 303 311 I-cancer
or 29 31 312 314 O
ER 32 34 315 317 O
- 34 35 317 318 O
negative 35 43 318 326 O
breast 44 50 327 333 B-cancer
cancer 51 57 334 340 I-cancer

Female 0 6 341 347 B-gender

Hemoglobin 0 10 348 358 B-clinical_variable
≥ 11 12 359 360 O
9.0 13 16 361 364 B-lower_bound
g 17 18 365 366 I-lower_bound
/ 18 19 366 367 I-lower_bound
dl 19 21 367 369 I-lower_bound

Impaired 0 8 370 378 B-chronic_disease
cardiac 9 16 379 386 I-chronic_disease
function 17 25 387 395 I-chronic_disease
or 26 28 396 398 O
history 29 36 399 406 O
of 37 39 407 409 O
cardiac 40 47 410 417 B-chronic_disease
problems 48 56 418 426 I-chronic_disease

Impaired 0 8 427 435 B-chronic_disease
renal 9 14 436 441 I-chronic_disease
function 15 23 442 450 I-chronic_disease

Non 0 3 451 454 B-cancer
- 3 4 454 455 I-cancer
Ductal 4 10 455 461 I-cancer
Pathology 11 20 462 471 O
: 20 21 471 472 O
Lobular 22 29 473 480 O
or 30 32 481 483 O
Colloid 33 40 484 491 O
type 41 45 492 496 O
presence 46 54 497 505 O

Pathological 0 12 506 518 O
diagnosis 13 22 519 528 O
of 23 25 529 531 O
Invasive 26 34 532 540 B-cancer
Ductal 35 41 541 547 I-cancer
Breast 42 48 548 554 I-cancer
Cancer 49 55 555 561 I-cancer
or 56 58 562 564 O
Ductal 59 65 565 571 B-cancer
Carcinoma 66 75 572 581 I-cancer
in 76 78 582 584 I-cancer
Situ 79 83 585 589 I-cancer
requiring 84 93 590 599 O
mastectomy 94 104 600 610 B-treatment

Pregnant 0 8 611 619 B-pregnancy
or 9 11 620 622 O
lactating 12 21 623 632 O

Presence 0 8 633 641 O
of 9 11 642 644 O
an 12 14 645 647 O
infection 15 24 648 657 B-chronic_disease
including 25 34 658 667 O
ulcerations 35 46 668 679 B-chronic_disease
and 47 50 680 683 O
fungal 51 57 684 690 B-chronic_disease
infections 58 68 691 701 I-chronic_disease
in 69 71 702 704 O
the 72 75 705 708 O
breast 76 82 709 715 O
to 83 85 716 718 O
be 86 88 719 721 O
studied 89 96 722 729 O

Presence 0 8 730 738 O
of 9 11 739 741 O
ascites 12 19 742 749 B-chronic_disease
( 20 21 750 751 O
as 21 23 751 753 O
determined 24 34 754 764 O
by 35 37 765 767 O
clinician 38 47 768 777 O
) 47 48 777 778 O

Presence 0 8 779 787 O
of 9 11 788 790 O
pleural 12 19 791 798 B-chronic_disease
effusion 20 28 799 807 I-chronic_disease

Presence 0 8 808 816 O
of 9 11 817 819 O
serious 12 19 820 827 O
infection 20 29 828 837 B-chronic_disease

Prior 0 5 838 843 B-treatment
radiation 6 15 844 853 I-treatment
to 16 18 854 856 O
the 19 22 857 860 O
breast 23 29 861 867 O
or 30 32 868 870 O
chest 33 38 871 876 O
wall 39 43 877 881 O

Scheduled 0 9 882 891 O
to 10 12 892 894 O
undergo 13 20 895 902 O
non 21 24 903 906 B-treatment
- 24 25 906 907 I-treatment
nipple 25 31 907 913 I-treatment
sparing 32 39 914 921 I-treatment
mastectomy 40 50 922 932 I-treatment
for 51 54 933 936 O
Invasive 55 63 937 945 O
Breast 64 70 946 952 B-cancer
Cancer 71 77 953 959 I-cancer
or 78 80 960 962 O
DCIS 81 85 963 967 B-cancer

Several 0 7 968 975 O
hepatic 8 15 976 983 B-chronic_disease
impairments 16 27 984 995 I-chronic_disease
, 27 28 995 996 O
define 29 35 997 1003 O
as 36 38 1004 1006 O
Child 39 44 1007 1012 B-clinical_variable
- 44 45 1012 1013 I-clinical_variable
Pugh 45 49 1013 1017 I-clinical_variable
Class 50 55 1018 1023 I-clinical_variable
C 56 57 1024 1025 I-clinical_variable
or 58 60 1026 1028 O
worse 61 66 1029 1034 O

Transaminases 0 13 1035 1048 O
( 14 15 1049 1050 O
AST 15 18 1050 1053 B-clinical_variable
/ 18 19 1053 1054 I-clinical_variable
SGOT 19 23 1054 1058 I-clinical_variable
and 24 27 1059 1062 O
ALT 28 31 1063 1066 B-clinical_variable
/ 31 32 1066 1067 I-clinical_variable
SGPT 32 36 1067 1071 I-clinical_variable
) 36 37 1071 1072 O
≤ 38 39 1073 1074 O
2.5 40 43 1075 1078 B-upper_bound
times 44 49 1079 1084 I-upper_bound
upper 50 55 1085 1090 I-upper_bound
limit 56 61 1091 1096 I-upper_bound
of 62 64 1097 1099 I-upper_bound
normal 65 71 1100 1106 I-upper_bound

Willing 0 7 1107 1114 B-contraception_consent
to 8 10 1115 1117 I-contraception_consent
use 11 14 1118 1121 I-contraception_consent
effective 15 24 1122 1131 I-contraception_consent
contraception 25 38 1132 1145 I-contraception_consent
for 39 42 1146 1149 O
at 43 45 1150 1152 O
least 46 51 1153 1158 O
28 52 54 1159 1161 B-lower_bound
- 54 55 1161 1162 I-lower_bound
days 55 59 1162 1166 I-lower_bound
post 60 64 1167 1171 O
study 65 70 1172 1177 O
drug 71 75 1178 1182 O
administration 76 90 1183 1197 O

bleeding 0 8 1198 1206 B-chronic_disease
diatheses 9 18 1207 1216 I-chronic_disease
, 18 19 1216 1217 O
thrombocytopenia 20 36 1218 1234 B-chronic_disease
or 37 39 1235 1237 O
current 40 47 1238 1245 O
anticoagulant 48 61 1246 1259 B-treatment
use 62 65 1260 1263 O

breast 0 6 1264 1270 B-treatment
surgery 7 14 1271 1278 I-treatment
which 15 20 1279 1284 O
interrupts 21 31 1285 1295 O
communication 32 45 1296 1309 O
of 46 48 1310 1312 O
the 49 52 1313 1316 O
ductal 53 59 1317 1323 O
systems 60 67 1324 1331 O
with 68 72 1332 1336 O
the 73 76 1337 1340 O
nipple 77 83 1341 1347 O

known 0 5 1348 1353 O
hypersensitivity 6 22 1354 1370 O
to 23 25 1371 1373 O
fulvestrant 26 37 1374 1385 B-allergy_name
or 38 40 1386 1388 O
any 41 44 1389 1392 O
of 45 47 1393 1395 O
its 48 51 1396 1399 O
formulation 52 63 1400 1411 O
components 64 74 1412 1422 O
including 75 84 1423 1432 O
castor 85 91 1433 1439 B-allergy_name
oil 92 95 1440 1443 I-allergy_name
, 95 96 1443 1444 O
alcohol 97 104 1445 1452 B-allergy_name
, 104 105 1452 1453 O
benzyl 106 112 1454 1460 B-allergy_name
alcohol 113 120 1461 1468 I-allergy_name
, 120 121 1468 1469 O
and 122 125 1470 1473 O
benzyl 126 132 1474 1480 B-allergy_name
benzoate 133 141 1481 1489 I-allergy_name

scheduled 0 9 1490 1499 O
to 10 12 1500 1502 O
undergo 13 20 1503 1510 O
nipple 21 27 1511 1517 B-treatment
sparing 28 35 1518 1525 I-treatment
mastectomy 36 46 1526 1536 I-treatment

